The Effects of Debanding on the Lung Expression of ET-1, eNOS, and cGMP in Rats with Left Ventricular Pressure Overload
Pulmonary hypertension (PH) usually develops secondary to left ventricular (LV) dysfunction; therefore, it is also called retrograde PH. To investigate our hypothesis that PH is at least partially reversible, as in some congenital heart diseases, in a rat model we investigated whether release of con...
Gespeichert in:
Veröffentlicht in: | Experimental biology and medicine (Maywood, N.J.) N.J.), 2006-06, Vol.231 (6), p.954-959 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Pulmonary hypertension (PH) usually develops secondary to left ventricular (LV)
dysfunction; therefore, it is also called retrograde PH. To investigate our hypothesis
that PH is at least partially reversible, as in some congenital heart diseases, in a rat
model we investigated whether release of constriction could attenuate pulmonary vascular
remodeling and change the expression of endothelin (ET)-1 and endothelial nitric oxide
synthase (eNOS). We used rats with LV dysfunction produced by an ascending aortic banding.
In this study, there were four groups enrolled: 4-weeks banded (AOB1–28;
n = 7), 7-weeks banded (AOB1–49; n = 7),
debanded groups (AOB1–28/DeB29–49; n = 7), and rats
receiving a sham operation (n = 7). Subsequently, there was significant
attenuation of medial hypertrophy in pulmonary arterioles and reversal of PH in the
AOB1–28/DeB29–49 group (sham, 19 ± 1.3 mm Hg; AOB1–28,
31 ± 2.7 mm Hg; AOB1–49, 32 ± 2.7 mm Hg; and
AOB1–28/DeB29–49, 20 ± 1.3 mm Hg). PreproET-1
mRNA and eNOS mRNA were measured by competitive reverse transcriptase
(RT) polymerase chain reaction (PCR), and eNOS was measured by Western blotting. Compared
with the banded groups, debanding significantly decreased pulmonary
preproET-1 mRNA, pulmonary ET-1 (sham, 210 ± 12 pg/g protein;
AOB1–28, 242 ± 12 pg/g protein; AOB1–49, 370 ± 49 pg/g protein;
and AOB1–28/DeB29–49, 206 ± 1.9 pg/g protein), and plasma ET-1
levels (sham, 10.1 ± 1.5 pg/ml; AOB1–28, 13.4 ± 2.0 pg/ml; AOB1–49,
15.4 ± 2.0 pg/ml; and AOB1–28/DeB29–49, 10.3 ± 0.9 pg/ml protein).
Debanding could not, however, alter pulmonary eNOS, eNOS mRNA, or cGMP.
These findings suggest that pulmonary vascular remodeling, increased pulmonary arterial
pressure, and upregulation of ET-1 gene expression are all reversible. We
infer that it is the upregulated gene expression of ET-1, not eNOS, that
is closely related to the development of the PH secondary to 4 weeks of aortic
banding. |
---|---|
ISSN: | 1535-3702 1535-3699 |
DOI: | 10.3181/00379727-231-2310954 |